ReviewFood science & nutrition2025
Synergistic Effects of Bioactive Compounds on Human Adiposity Mechanisms of Fat Loss and Fat Accumulation.
Review in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synergistic Effects of Bioactive Compounds on Human Adiposity Mechanisms of Fat Loss and Fat Accumulation.Food science & nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adipose tissue plays a crucial role in regulating metabolic health in humans, where both an excess and a deficiency can lead to chronic diseases. Bioactive compounds derived from food like polyphenols, alkaloids, terpenoids, peptides, and fibers have been recognized as significant influencers of fat metabolism. They operate through various molecular and systemic pathways, facilitating either adiposity reduction or fat accumulation based on the physiological context. This review consolidates recent progress in comprehending the mechanisms through which these compounds affect lipolysis, adipogenesis, thermogenesis, and appetite regulation. We emphasize the collaborative effects that enhance bioactive efficacy and examine findings from clinical trials focused on obesity, cachexia, and sarcopenia. For example, co-administration of curcumin with piperine increased curcumin bioavailability up to 20-fold, and epigallocatechin gallate (EGCG) combined with caffeine modestly enhanced 24-h energy expenditure by 4% in humans. Similarly, omega-3 fatty acids combined with vitamin D supplementation improved lean mass by 1.2 kg in sarcopenic adults in recent meta-analyses. New platforms in personalized nutrition-combining genomics, microbiome analysis, and AI-driven meal planning-present exciting opportunities for tailored applications. In conclusion, we address significant translational challenges and prospective pathways, focusing on enhancing bioavailability, standardizing outcomes, and ethically expanding personalized interventions. This work highlights the promise of bioactives as effective means for influencing adipose biology and enhancing metabolic health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.